PHMMF (Pharma Mar) Other Net Income (Loss) : $0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Pharma Mar Other Net Income (Loss)?

Pharma Mar's Other Net Income (Loss) for the three months ended in Mar. 2025 was $0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was $0.0 Mil.

Pharma Mar's quarterly Other Net Income (Loss) declined from Sep. 2024 ($0.0 Mil) to Dec. 2024 ($-0.0 Mil) but then increased from Dec. 2024 ($-0.0 Mil) to Mar. 2025 ($0.0 Mil).

Pharma Mar's annual Other Net Income (Loss) increased from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($0.0 Mil) but then declined from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($0.0 Mil).

Pharma Mar Other Net Income (Loss) Historical Data

The historical data trend for Pharma Mar's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Other Net Income (Loss) Chart

Pharma Mar Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Pharma Mar Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Pharma Mar Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Pharma Mar Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (OTCPK:PHMMF) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

PHMe:UK 0RC6:UK PHM:Spain PMRA:Germany PHM:Austria

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.